GPT and Hyperbilirubinemia: We found that common adverse events of any grade in the Atez/Bev group mainly included elevated levels of aspartate aminotransferase (AST) (76.2% vs. 53.6%, p = 0.139) and alanine aminotransferase (ALT) (66.7% vs. 46.4%, p = 0.246), and hyperbilirubinemia (52.4% vs. 28.6%, p = 0.139) compared with those in the LEN group.